Abstract
Background: Endovascular intervention is now the primary line of treatment for patients with critical limb ischemia.Nevertheless, endovascular experts face several obstacles with these treatments due to the existence of broad multilevellesions, osteal lesions, and lengthy and entire chronic occlusive lesions.Aim of this work: Evaluation the different endovascular techniques of management the superficial femoral arteryosteal lesions in cases with critical limb ischemia or incapacitating claudication.Patients and Methods: This is a prospective study of 55 patients who presented to Beni Suef University Hospitals’vascular surgery unit between January 2020 and December 2021. Patients with symptomatic atherosclerotic occlusivedisease of the osteal region of SFA are included in the research.Results: Technical success was done in 92.7% of cases. Figure (4) shows that;the mean hospital stay of cases in thisstudy was 1.53 ± 0.81 days with range (1.0 – 4.0).Follow up at 1 and 3 months revealed that; patency was kept in 51(100%), 49 (96.07%) and 40 (78.43%) of all technical successful cases in one, three and six months respectively.Conclusion: Endovascular treatments show promising prospects as treatment options for SFA atherosclerotic occlusivedisorders, particularly when osteal lesions are present. Endovascular intervention techniques, facilities, and expertisehave greatly improved, resulting in a high technical success rate and a high proportion of lower limb patency in CLIpatients.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.